Case File
efta-01452434DOJ Data Set 10OtherEFTA01452434
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01452434
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
US
Healthca re
Propsed
Updated Current
Total
Equity
Bristol Myers
$
2.50
$
2.00
$
2.00
Pfizer
$
2.50
$
2.00
$
2.00
Merck
$
2.50
$
2.00
$
2.00
Valeant
$
1.50
$
1.00
$
1.00
Actavis
$
1.50
$
1.00
$
1.00
Gilead
$
1.50
$
2.00
$
2.00
Mylan
$
1.00
$
1.00
$
1.00
Endo Health
$
1.00
$
1.00
$
1.00
HCA
$
030
$
1.00
$
1.00
Rite Aid
$
0.50
$
0.50
$
0.50
Ariad
$
0.10
$
0.10
Biogen
$
0.40
$
0.W
$
1.00
Sangamo Biosciences
$
1.00
$
1.00
Agerion
$
0.50
$
0.50
Foundation Medical
$
0.70
$
0.70
CVS
$
1.00
$
1.00
Sub Total
$ 15.00
$ 15.40
$
2.40
$ 17.80
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0109439
CONFIDENTIAL
SDNY_GM_00255623
EFTA01452434
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.